EPISODE 26 - Dangers of Low-Salt Diets & Impacts on Athletic Performance w/ Dr. James DiNicolantonio

In this episode, Dr. Bubbs sits down with expert researcher Dr. James DiNicholantonio PhD and takes a deep dive into all things salt: why we are so afraid of it, where today’s standard recommendations came from, dangers of a low-salt diet on health, impacts of salt for high performance, the sugar/salt connection and so much more. James highlights the many myths around salt, why it’s important to get your daily dose, what the ideal salt dose truly is and different types of salt to support better health and performance. 

Salt "Lay-Ups"

1)    Salt is essential for your health (it makes up 90% of your total electrolytes).

2)    Only a few hundred years ago, we consumed 10x the amount of salt that we do today.

3)    Low-salt diets expose you to many health risks and today’s current recommendation of 2,300mg per day is likely too low for most people.

Performance Hacks

1)    Contrary to common belief, our hunter-gatherer ancestors may have consumed high salt diets via the salty blood, interstitial fluid and organs which contain robust amounts of salt.

2)    Low salt diets can increase insulin AUC by up to 70%!

3)    Redmond Real Salt – clean, trace mineral dense and high in iodine.

Coffee Talk

James’ “Salty” Coffee – 1 Large Black Coffee (+ pinch of Redmand salt)

About Dr. James DiNicholantonio

Dr. James DiNicolantonio is a cardiovascular research scientist and doctor of pharmacy at Saint Luke’s Mid America Heart Institute in Kansas City, Missouri. A well-respected and internationally known scientist, and expert on health and nutrition, he serves as the Associate Editor of the British Medical Journal’s (BMJ) Open Heart, a journal published in partnership with the British Cardiovascular Society. He is the author or coauthor of approximately 200 publications in the medical literature, as well as the his new book The Salt Fix. He is also on the Editorial Advisory Board of several other medical journals, including Progress in Cardiovascular Diseases and International Journal of Clinical Pharmacology & Toxicology (IJCPT). Learn more about James' research here and follow him on twitter